Icahn Sells Allergan

We learned from Carl Icahn's Q3 13F filing that Carl sold most of his Allergan. We haven't learned much more on this transaction as either nobody seems to care or therein lies a treasure - opportunity.

Shares of Allergan (NYSE:AGN) closed at $192.25 on Friday down ~36% for 2016 and ~24% since I published "Is Allergan Bubbling?" I received a bit of grief after that story as you can see included in some of the comments. Looking back, the market seems to have validated my valuation concerns appointing such a fine haircut. But is Allergan still Bubbling?

Would Carl Icahn have sold if he thought that Allergan's share price was going higher? Surely he's been wrong before. However, he also likes to get out early. The facts suggest to me that Allergan's bubble has not finished bursting and Carl got out early. Here's why:

READ FULL ARTICLE HERE